Provided by Tiger Trade Technology Pte. Ltd.

AgeX Therapeutics Inc

11.10
-1.5000-11.90%
Volume:- -
Turnover:44.26K
Market Cap:27.76M
PE:-0.85
High:11.10
Open:11.10
Low:11.10
Close:11.10
52wk High:35.17
52wk Low:10.90
Shares:2.50M
Float Shares:606.40K
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-13.0212
EPS(LYR):-9.6973
ROE:306.76%
ROA:-81.88%
PB:5.08
PE(LYR):-1.14

Loading ...

Apr 06, 2022

Major Issues Report

8-K - Current report
Mar 29, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 29, 2022

Major Issues Report

8-K - Current report
Mar 03, 2022

Major Issues Report

8-K - Current report
Feb 22, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Feb 15, 2022

Major Issues Report

8-K - Current report
Feb 14, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Feb 04, 2022

Major Issues Report

8-K - Current report
Jan 04, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Dec 30, 2021

Major Issues Report

8-K - Current report
Dec 13, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Dec 09, 2021

Major Issues Report

8-K - Current report
Sep 21, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Sep 14, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Sep 03, 2021

Major Issues Report

8-K - Current report
Aug 13, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 13, 2021

Major Issues Report

8-K - Current report
Jul 23, 2021

Major Issues Report

8-K - Current report
Jul 20, 2021

Major Issues Report

8-K - Current report
May 26, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership